Liver transplantation for intrahepatic cholangiocarcinoma: ready for prime time?

G Sapisochin, T Ivanics, J Heimbach - Hepatology, 2022 - Wiley Online Library
Cholangiocarcinoma (CCA) represents the second‐most common primary liver malignancy
after HCC and has risen in incidence globally in the past decades. Intrahepatic …

New challenges in the management of cholangiocarcinoma: the role of liver transplantation, locoregional therapies, and systemic therapy

E Mauro, J Ferrer-Fàbrega, T Sauri, A Soler, A Cobo… - Cancers, 2023 - mdpi.com
Simple Summary Cholangiocarcinoma (CCA) is a highly lethal neoplasia, which incidence
has steadily increased in the last years. Although surgical resection remains the cornerstone …

EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma

D Alvaro, GJ Gores, J Walicki, C Hassan… - Journal of …, 2023 - Elsevier
Intrahepatic cholangiocarcinoma (iCCA) develops inside the liver, between bile ductules
and the second-order bile ducts. It is the second most frequent primary liver cancer after …

Treatment of Intrahepatic Cholangiocarcinoma—a multidisciplinary approach

F Krenzien, N Nevermann, A Krombholz, C Benzing… - Cancers, 2022 - mdpi.com
Simple Summary This review discusses multimodality treatment strategies for intrahepatic
cholangiocarcinoma (iCC). Surgical resection remains the only potentially curative …

[HTML][HTML] Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances

A Borakati, F Froghi, RH Bhogal… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Cholangiocarcinoma (CCA) is an aggressive malignancy arising from the biliary epithelium.
It may occur at any location along the biliary tree with the perihilar area being the most …

[PDF][PDF] 欧洲肝脏研究协会及国际肝癌协会2023 版《 肝内胆管癌治疗临床实践指南》 更新解读

覃德龙, 陈家璐, 唐玥, 汤朝晖, 全志伟 - 中国普通外科杂志, 2023 - zpwz.net
摘要欧洲肝脏研究协会(EASL) 及国际肝癌协会(ILCA) 于2023 年发布最新的《
肝内胆管癌治疗临床实践指南》(简称新版指南). 相较于EASL-ILCA 在2014 …

Intrahepatic cholangiocarcinoma: the role of liver transplantation, adjunctive treatments, and prognostic biomarkers

AA Connor, S Kodali, M Abdelrahim, MM Javle… - Frontiers in …, 2022 - frontiersin.org
Intrahepatic cholangiocarcinoma (iCCA) is a primary epithelial cell malignancy of the liver
with rising incidence rate globally. Its insidious presentation, heterogeneous and aggressive …

Comparison of resection versus liver transplantation for intrahepatic cholangiocarcinoma: past, present, and future directions

S Kodali, AA Connor, S Thabet, EW Brombosz… - … & Pancreatic Diseases …, 2023 - Elsevier
Intrahepatic cholangiocarcinoma (iCCA) is a rare biliary tract cancer with high mortality rate.
Complete resection of the iCCA lesion is the first choice of treatment, with good prognosis …

A systematic review and meta‐analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocols

TC Wu, CP Smith, JS Li, J Burton… - Journal of surgical …, 2024 - Wiley Online Library
Abstract Background and Objectives Many heterogenous orthotopic liver transplant (OLT)
protocols exist for patients with unresectable cholangiocarcinoma. Little is known about the …

[PDF][PDF] Liver transplantation as an alternative for the treatment of intrahepatic cholangiocarcinoma: Past, present, and future directions

S Kodali, AA Connor, S Thabet… - … & Pancreatic Diseases …, 2024 - binasss.sa.cr
abstract Intrahepatic cholangiocarcinoma (iCCA) is a rare biliary tract cancer with high
mortality rate. Complete resection of the iCCA lesion is the first choice of treatment, with …